Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Analyst
Los Angeles, USA
7+ years of experience
Dustin joined Datamonitor Healthcare in the summer of 2015. One of the highlights of his role has been analyzing the development of novel therapies from the early pre-clinical and clinical phases, through final approval and marketing authorization. Having been involved in cancer research as a graduate student, Dustin is fascinated by new compounds or mechanisms of action and their impact on the oncology treatment space, both from a clinical and commercial viewpoint.
He has a Bachelor of Science in Applied and Computational Mathematics and a PhD in Biological Sciences, both from the University of California, Irvine.
Datamonitor Healthcare, Biomedtracker
By Dustin Phan 27 Nov 2020
The effect of COVID-19 on clinical trials, the industry response, and the return to full operations
Topic Coronavirus Clinical Trials
Datamonitor Healthcare
By Dustin Phan 21 Jul 2015
Takeda announced the submission of a New Drug Application for ixazomib, the first orally administered proteasome inhibitor for multiple myeloma. On 14 July 2015, Takeda announced the
Scrip
30 Nov 2015
Scrip
11 Nov 2015
